PHARMA SNAKES: Thirteen irrefutable FACTS about snake venom, Big Pharma and biological weapons | NaturalNews.com

Friday, April 15, 2022 by: Mike Adams

(Natural News) As the concept of “venom theory” has reverberated around the world this week, many people are shocked to realize how many pharmaceutical medications are derived almost entirely from rattlesnake venom, Gila Monster reptile venom, pit viper venom, scorpion venom and other such sources.

A pain treatment drug named Prialt (see Prialt.com) is actually synthesized by copying the poison of the Magical Cone Snail (conus magus). This poison produces hallucinations, confusion, altered states of consciousness and more. The insert sheet for the Prialt drug carries bizarre warnings such as, “Patients have become unresponsive or stuporous while receiving PRIALT.”

Read More & videos: PHARMA SNAKES: Thirteen irrefutable FACTS about snake venom, Big Pharma and biological weapons — NaturalNews.com

VenomTech company announces massive library of SNAKE VENOM peptides for pharmaceutical development; “nanocarriers” stabilize snake venom in WATER (PubMed) | NaturalNews.com

Wednesday, April 13, 2022 by: Mike Adams

(Natural News) Astonishingly, it is rapidly becoming apparent in the aftermath of the Dr. Bryan Ardis revelations about snake venom origins for covid-19 that many people — even some in alt media — are completely unaware that snake venom is commonly used as the starting point for pharmaceutical research.

Earlier today, a UK company literally named “Venomtech” announced a massive venom peptide and venom fragment library to be used for drug discovery by pharmaceutical companies (as well as pesticide used for agricultural companies).

Read more & Here are parts 1 and 2 of recent interview with Dr. Bryan Ardis, followed by Situation Update podcast which further analyzes what may be going on with snake venom and covid-19 (also now called “Covenom-19”): https://www.naturalnews.com/2022-04-13-venomtech-company-announces-massive-library-of-snake-venom-peptides-for-pharmaceutical-deployment.html